Knee replacement patients may walk sooner with new anesthetic combo
NCT ID NCT07239999
First seen Nov 20, 2025 · Last updated Jun 23, 2026 · Updated 23 times
Summary
This study tests two different freezing medications given in the spine for knee replacement surgery. The goal is to see which one lets patients move their legs and leave the hospital faster. 170 adults having outpatient knee replacement will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
spinal anesthetics (chloroprocaine vs mepivacaine)
What this could lead to
If one anesthetic works faster, patients could move their legs sooner and go home earlier after knee replacement surgery.
What could go wrong
This is a small, early-phase trial comparing two existing drugs, so it is unlikely to lead to a major breakthrough. Results may not apply to all patients.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.